Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

California Institute for Regenerative Medicine to fund stem cell research at Cedars-Sinai Heart Institute

17.07.2008
Studies seek stem cell therapies for heart attacks, heart failure and pacing disorders

The California Institute for Regenerative Medicine (CIRM) has awarded a planning grant to the Cedars-Sinai Heart Institute to support its researchers in their study of regenerative stem cell-based approaches to heart attacks, congestive heart failure and pacing abnormalities.

Cedars-Sinai research teams are currently conducting stem cell studies in several disciplines – often using stem cells derived from bone marrow and other sources in the body – but this is the first funding the medical center has received from CIRM, which was established in 2005 to fund stem cell research at California research institutions. The grant is to be applied toward planning and developing upcoming studies.

The grant was awarded to Eduardo Marbán, M.D., Ph.D., a world-renowned stem cell researcher and cardiologist who joined Cedars-Sinai last year as the founding director of its Heart Institute. Building on Cedars-Sinai’s decades-long strengths in cardiology, cardiac surgery and cardiac imaging, the Cedars-Sinai Heart Institute integrates state-of-the-art research in heart disease and prevention with one of the nation’s highest-quality patient-care programs.

In studies scheduled to begin at Cedars-Sinai later this year, autologous (derived from patients themselves) stem cells will be used to treat heart attack and heart failure. Studies in these areas are advanced and are expected to provide clinical results within a few years. The goal is to have stem cells providing healthy new heart cells to replace those damaged by disease.
... more about:
»Cell »Heart »Stem

For the development of “biological pacemakers,” the researchers will be studying whether human embryonic stem cells can be engineered to become heart pacing cells that could be implanted to actually restore a heart’s natural rhythm, even responding to varying demands – something artificial pacemakers can’t do. The complex process of creating biological pacemakers appears feasible in laboratory work but needs to progress through years of development and preclinical trials before being approved for human studies.

Sandy Van | prpacific.com
Further information:
http://www.cedars-sinai.edu

Further reports about: Cell Heart Stem

More articles from Life Sciences:

nachricht Scientists spin artificial silk from whey protein
24.01.2017 | Deutsches Elektronen-Synchrotron DESY

nachricht Choreographing the microRNA-target dance
24.01.2017 | UT Southwestern Medical Center

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Scientists spin artificial silk from whey protein

X-ray study throws light on key process for production

A Swedish-German team of researchers has cleared up a key process for the artificial production of silk. With the help of the intense X-rays from DESY's...

Im Focus: Quantum optical sensor for the first time tested in space – with a laser system from Berlin

For the first time ever, a cloud of ultra-cold atoms has been successfully created in space on board of a sounding rocket. The MAIUS mission demonstrates that quantum optical sensors can be operated even in harsh environments like space – a prerequi-site for finding answers to the most challenging questions of fundamental physics and an important innovation driver for everyday applications.

According to Albert Einstein's Equivalence Principle, all bodies are accelerated at the same rate by the Earth's gravity, regardless of their properties. This...

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Breaking the optical bandwidth record of stable pulsed lasers

24.01.2017 | Physics and Astronomy

Choreographing the microRNA-target dance

24.01.2017 | Life Sciences

Spanish scientists create a 3-D bioprinter to print human skin

24.01.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>